Animal Sedative Market Size Worth $489 million by 2031

Animal Sedative Market Growth, Trends and Report Highlights

According to a new report, published by KBV research, The Global Animal Sedative Market size is expected to reach $489.1 million by 2031, rising at a market growth of 5.5% CAGR during the forecast period.

The Parenteral segment is showcasing a CAGR of 5.2 % during the forecast period. When administered parenterally, sedatives enter the bloodstream directly, leading to a rapid onset of action. This is particularly important in emergencies or when immediate sedation is required. Parenteral administration allows veterinarians to administer sedatives in precise dosages, ensuring the desired level of sedation is achieved quickly and effectively.

The Dogs segment is generating the highest revenue in the Global Animal Sedative Market by Animal Type in 2023; thereby, achieving a market value of $186.6 million by 2031. Dogs are among the most popular pets worldwide, leading to a substantial population that requires veterinary care. Many dog owners drive the demand for veterinary services, including sedatives.

The Alpha-2 Adrenergic Receptor Agonists segment is registering a CAGR of 4.6 % during the forecast period. Alpha-2 adrenergic receptor agonists, such as xylazine, medetomidine, and dexmedetomidine, provide both sedation and analgesia. This dual effect makes them highly effective for various veterinary procedures, reducing the need for additional pain management drugs.

The Hospitals segment led the Global Animal Sedative Market by End Use in 2023; thereby, achieving a market value of $247.4 million by 2031. Veterinary hospitals handle many complex medical procedures, including surgeries, diagnostic imaging, and dental work, often requiring sedation or anesthesia to ensure the animal remains still and calm.

The Surgical segment is growing at a CAGR of 5.2 % during the forecast period. Animal sedatives are essential for pre-anesthetic medication, helping to calm and relax animals before they receive general anesthesia for surgical procedures. This preparation aims to achieve a more seamless anesthesia induction process while minimizing the stress and anxiety typically associated with surgery.

Full Report: https://www.kbvresearch.com/animal-sedative-market/

The North America region dominated the Global Animal Sedative Market by Region in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $182.1 million by 2031. The Europe region is anticipated to grow at a CAGR of 5.4% during (2024 - 2031). Additionally, The Asia Pacific region would witness a CAGR of 6% during (2024 - 2031).

List of Key Companies Profiled

• Zoetis, Inc.
• Virbac
• Dechra Pharmaceuticals PLC
• Merck & Co., Inc.
• Bimeda, Inc.
• Ouro Fino Saude Animal Participacoes S.A.
• vetcare.fi.
• Chanelle Pharma (Exponent)
• Randlab Australia Pty Ltd.
• Troy Laboratories Pty Ltd.

Animal Sedative Market Report Segmentation

By Route of Administration

• Parenteral
• Oral

By Animal Type

• Dogs
• Cats
• Horses
• Others

By Drug Class

• Alpha-2 Adrenergic Receptor Agonists
• Phenothiazines
• Benzodiazepines
• Butyrophenones
• Others

By End Use

• Hospitals
• Specialty Centers

By Application

• Surgical
• Diagnostic
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Related Reports:

North America Animal Sedative Market Size, Industry Trend 2031

• July-2024
• 118 Pages

LAMEA Animal Sedative Market Size & Growth Report | 2031

• July-2024
• 134 Pages

Europe Animal Sedative Market Size, Share & Forecast, 2031

• July-2024
• 135 Pages

Asia Pacific Animal Sedative Market Size, Growth 2031

• July-2024
• 138 Pages